Kevin H. Douglas

Member

Nashville

(615) 742-7767

kdouglas@bassberry.com

https://www.bassberry.com/professionals/douglas-kevin-h/

Notice

Visiting, or interacting with, this website does not constitute an attorney-client relationship. Although we are always interested in hearing from visitors to our website, we cannot accept representation on a new matter from either existing clients or new clients until we know that we do not have a conflict of interest that would prevent us from doing so. Therefore, please do not send us any information about any new matter that may involve a potential legal representation until we have confirmed that a conflict of interest does not exist and we have expressly agreed in writing to the representation. Until there is such an agreement, we will not be deemed to have given you any advice, any information you send may not be deemed privileged and confidential, and we may be able to represent adverse parties.

vCard

Kevin Douglas is the Chair of the firm’s Corporate & Securities Practice Group. He has deep experience representing public companies on corporate and securities laws related matters, including companies within the healthcare industry. Kevin’s public company practice focuses on corporate governance matters, securities laws compliance, mergers and acquisitions, corporate finance and shareholder activism. His representative experience has ranged from providing SEC disclosure advice to the audit committee of a Fortune 100 company to representing an NYSE-listed company in connection with its $4.3 billion acquisition by another public company to representing another NYSE-listed company in connection with its issuance of $2.2 billion in senior notes. Kevin has also represented private companies in a wide variety of mergers and acquisition matters.

Kevin represents public companies, private equity-backed companies and other private companies. His broad corporate practice involves:

Mergers & Acquisitions – Representing public and private companies in connection with mergers and acquisitions.
Corporate Finance – Advising clients in connection with public offerings, Rule 144A offerings, private placements and venture capital investments.
Securities Laws Compliance – Advising public company clients in connection with the preparation of Form 10-Ks, 10-Qs, 8-Ks, proxy statements and earnings releases.
Corporate Governance – Providing clients with advice related to compliance with the Sarbanes-Oxley Act of 2002, the Dodd-Frank Act and other federal securities laws requirements; compliance with stock exchange corporate governance listing standards, committee charters and corporate governance guidelines, board and committee composition issues, internal control and disclosure control matters, Regulation FD, insider trading policies and 10b5-1 trading plans.
Shareholder Activism – Assisting with shareholder rights plans, proxy access bylaws, contested director elections, classified boards, advance notice bylaws, Rule 14a-8 shareholder proposals, ISS and other proxy advisory firm-related matters, and Section 13 of the Securities Exchange Act and standstill agreements.
Executive Compensation – Advising on executive compensation disclosure requirements applicable to public companies and related topics.

Kevin is the co-editor of the firm’s Securities Law Exchange blog, where he provides commentary on a variety of corporate and securities law issues.

Prior to joining the firm, Kevin practiced at Latham & Watkins in Washington, D.C. and Sherrard & Roe, PLC in Nashville.

Featured Experience

Disclosure Counsel for Audit Committee of Board of Directors of Bank of America

Engaged in 2010 to serve as independent disclosure counsel to the Audit Committee of the Board of Directors of Bank of America pursuant to a settlement order entered into by Bank of America and the SEC

We were engaged in 2010 to serve as independent disclosure counsel to the Audit Committee of the Board of Directors...

Read More
Client Type: Public Company

Memberships

American Bar Association

American Health Law Association (AHLA)

Representative Experience

Disclosure Counsel for Audit Committee of Board of Directors of Bank of America

Engaged in 2010 to serve as independent disclosure counsel to the Audit Committee of the Board of Directors of Bank of America pursuant to a settlement order entered into by Bank of America and the SEC

We were engaged in 2010 to serve as independent disclosure counsel to the Audit Committee of the Board of Directors...

Read More
Client Type: Public Company

Accel-KKR Acquires Forcura, LLC

Representation of Forcura, LLC, a healthcare technology that facilitates continuity of care, in its sale to Accel-KKR, a Silicon Valley-based technology-focused private equity firm

We represented Forcura, LLC, a healthcare technology that facilitates continuity of care, in its sale to Accel-KKR, a Silicon Valley-based...

Read More
Client Type: Private Company
Addus HomeCare Completes Four Acquisitions, Public Stock Offering

Represented Addus HomeCare Corporation (Nasdaq: ADUS) in four strategic acquisitions and in its underwritten public offering of 2.3 million shares of common stock in 2019.

We represented Addus HomeCare Corporation (Nasdaq: ADUS) in four strategic acquisitions in 2019, including the acquisition of Hospice Partners of...

Read More
Client Type: Public Company
Pace Payment Systems Sold to i3 Verticals

Represented Pace Payment Systems, Inc. in its sale to i3 Verticals, Inc. for $52.7 million

We represented Pace Payment Systems, Inc. in its sale to i3 Verticals, Inc. for $52.7 million, plus an earnout payment...

Read More
Client Type: Private Company
Engility Holdings Merges with SAIC for $2.5 Billion

Represented Engility Holdings in its merger with Science Applications International Corp. in which SAIC acquired Engility in an all-stock transaction valued at $2.5 billion

We represented Engility Holdings (NYSE: EGL) in its merger with Science Applications International Corp. (NYSE: SAIC) in which SAIC acquired...

Read More
Client Type: Public Company
Change Healthcare Investment in MDSave

Representation of Change Healthcare in its strategic investment for a minority position in MDsave, a technology and healthcare payments company that simplifies the healthcare services shopping and payment experience for consumers

We represented Change Healthcare in its strategic investment for a minority position in MDsave, a technology and healthcare payments company...

Read More
Client Type: Private Company
Addus HomeCare August 2018 Common Stock Offering

Addus Homecare August 2018 Common Stock Offering

We represented Addus HomeCare Corporation (Nasdaq: ADUS) in its public offering of 2,100,000 shares of common stock for net proceeds...

Read More
Client Type: Public Company
i3 Verticals, Inc. 2018 Initial Public Offering

Represented i3 Verticals, Inc. in its initial public offering (IPO) of of 7,647,500 shares of Class A common stock for a total net proceeds of $92.5 million.

We represented i3 Verticals, Inc. in its initial public offering (IPO) of 7,647,500 shares of Class A common stock for...

Read More
Client Type: Public Company
Change Healthcare Acquires National Decision Support Company

Represented Change Healthcare in its acquisition of National Decision Support Company

We represented Change Healthcare in its acquisition of National Decision Support Company (NDSC), a leader in cloud-based solutions that delivers...

Read More
Client Type: Private Company
CenseoHealth Sold to New Mountain Capital

Represented CenseoHealth in its sale to New Mountain Capital

We represented CenseoHealth in its sale to New Mountain Capital. The transaction closed in December 2017 and terms of the...

Read More
Client Type: Private Company
CHS Completes $900 Million Senior Secured Notes Tack-on Offering

Represented CHS in its $900 million secured notes tack-on offering

We represented Community Health Systems, Inc. (NYSE: CYH) in its tack-on offering of $900 million aggregate principal amount of 6.250%...

Read More
Client Type: Public Company

Accolades

IFLR1000 — Notable Practitioner

Vanderbilt Law Review — Member (1996-1998)

Education

Vanderbilt Law School - J.D., 1998

Order of the Coif
University of Virginia - B.A., 1995

Admissions

District of Columbia, 2000
Tennessee, 1998

Securities Law Exchange Blog

Featuring commentary and practical insight on SEC updates for publicly traded companies. Visit Now

Kevin H. Douglas

Notice

Featured Experience

Memberships

Representative Experience

Publications

Past Events

Media Mentions & Firm News

Accolades

Related Services

Education

Admissions

Securities Law Exchange Blog